Day 1
Mon 26 Jul
Advancing Next-Generation Vaccines, Immunology and Immunotherapy for Global Health
Congress begins in

VaccineX-2027 brings together researchers, clinicians, immunologists, vaccinologists, biotech innovators, public health professionals and industry leaders to discuss advances in vaccine science, immune regulation and immunotherapy.
The congress will highlight next-generation vaccine platforms, mRNA and nucleic acid technologies, infectious disease preparedness, cancer vaccines, tumor immunology, immune cell engineering, biomarkers, AI-enabled vaccine design and emerging approaches in immune medicine.
The program is designed for academic researchers, pharmaceutical and biotechnology professionals, healthcare specialists, policy stakeholders, students and solution providers working across vaccines, immunology and immunotherapy.
Steering committee members curating the scientific programme.
Keynote and plenary speakers — open a profile for the full bio.
Speakers will appear here once published in the CMS.
Explore the scientific programme organised into focused tracks and subtracks.
Modern vaccine platform science spanning recombinant, viral-vector, protein, DNA, RNA and broad-spectrum approaches.
4 subtracks
RNA vaccine and therapeutic design, delivery and immunogenicity with a focus on LNP-enabled platforms.
4 subtracks
Therapeutic vaccination and precision immune strategies for oncology applications.
4 subtracks
Engineered immune-cell therapies for cancer and immune-mediated disease.
4 subtracks
Gene editing, gene delivery and gene-regulating technologies for immune medicine.
4 subtracks
Engineered antibodies and immune-targeting biologics for infectious disease, cancer and immune disorders.
4 subtracks
Three days of keynotes, technical sessions and collaboration — the detailed timetable publishes as sessions are confirmed.
Day 1
Mon 26 Jul
Day 2
Tue 27 Jul
Day 3
Wed 28 Jul
VaccineX-2027 convenes vaccinologists, immunologists, clinicians, biotech innovators and public-health leaders shaping next-generation vaccines and immunotherapy.
Scientists designing next-generation vaccine platforms and trials.
Researchers mapping immune regulation, memory and correlates of protection.
Teams translating immunology into infectious disease and cancer care.
Innovators scaling nucleic-acid, protein and novel delivery systems.
Professionals strengthening preparedness, equity and immunisation programmes.
Experts aligning safety, quality and access for new immune therapies.
Abstract Submission
16 April 2027
Registration Opens
19 August 2026
Early Bird Registration
30 September 2026
Standard Registration
5 March 2027
On-Spot Registration
26 July 2027
Choose the pass that fits your participation. Complete registration on EventPortal.
| Category | Details | Standard | Early Bird | On-Spot | Information |
|---|---|---|---|---|---|
| Speaker Registration |
| €779.00 | €679.00 | €979.00 | |
| Delegate Registration | €899.00 | €799.00 | €1,099.00 | ||
| Poster Registration | €449.00 | €349.00 | €649.00 | ||
| Student Registration | €329.00 | €229.00 | €529.00 |
News
The World Congress on Vaccines, Immunology and Immunotherapy is planned for July 26-28, 2027 in London, UK.
Researchers are invited to prepare abstracts across 15 scientific tracks covering vaccines, immune science and immunotherapy.

Venue & Contact
Join us in London — a global hub for vaccines, immunology and immunotherapy.
July 26–28, 2027 · London
Register today to secure early-bird pricing, or submit your abstract to present your research to an international audience.